The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: The Padua province experience
Raffaele Pesavento, Davide Ceccato, Giampaolo Pasquetto, Jacopo Monticelli, Lucia Leone, Annachiara Frigo, Davide Gorgi, Anna Postal, Giuseppe Marchese, Alberto Cipriani, Alois Saller, Cristiano Sarais, Pietro Criveller, Marco Gemelli, Federico Capone, Paola Fioretto, Claudio Pagano, Marco Rossato, Angelo Avogaro, Paolo Simioni, Paolo Prandoni, Roberto Vettor
Topics & Concepts
Critically illCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineHazardVirologyInternal medicineDiseaseInfectious disease (medical specialty)ChemistryOrganic chemistryOutbreakCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and Management